Leukodytrophy in Children: 12 Cases
Main Article Content
Abstract
Introduction: Leukodystrophies are a rare geneLc disease characterized by damage of the myelin sheath. They represent a large number of diseases that are heterogeneous by their clinical and physiopathological aspects.
Material and Methods: We report 12 cases of leukodystrophies collected at the Neuropediatric Unit of Abderrahim Harouchi Mother and Child Hospital CHU Ibn Rochd, Casablanca, Morocco. Results: The average age of diagnosis was 2 years and 9 months, with a predominance of females (sex raLo:0.33). Consanguinity was found in 5 cases. The onset symptomatology was dominated by psychomotor regression, found in 8 paLents, and seizures in 4 paLents. Motor signs were in the foreground: pyramidal syndrome in 5 cases, hypotonia in 4 cases, tetraparesis in 1 case, dysarthria in 1 case. The lumbar puncture, carried out in 4 paLents, revealed hyperproteinorachy in 3 cases, glycorachy and cytological study were normal. We noLced a decreased level of Aryllsulfatase A in 6 cases. Imaging was performed in all paLents and showed diffuse white ma]er demyelinaLon. MRI allowed us to classify our cases and showed 7 cases of metachromaLc leukodystrophy, 1 case of cavitary leukodystrophy, 1 case of Refsum disease, 1 case of Canavan disease, 1 case of Cockaynes syndrome and 1 case of adrenoleukodystrophy. The electroneuromyogram showed a decrease in nerve conducLon velociLes in 2 cases. Molecular study was performed in one paLent finding a hyccin mutaLon.
Conclusion: The diagnosis of leukodystrophies is o_en difficult because of their clinical heterogeneity. The partnership of clinicians with geneLcists may be the key point to improve diagnosis and therapeuLc management.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Maria BL, Deidrick KM, Moser H, Naidu S. Leukodystrophies: pathogenesis, diagnosis, strategies, therapies, and future research direcLons. J Child Neurol 2003;18:578–90.
II. Gieselmann V. MetachromaLc leukodystrophy: recent research developments. J Child Neurol 2003;18:591–4.
III. S.Makri-morkrane.S.Meziche. I.Talaboulma : les LD métaboliques pédiatrique : notre experience .Elhakim N 29 . Vol IV Avril 2020 .
IV. Turpin J.-C., Gray F. et Baumann N. LD EdiLons Techniques-Ency.Méd.Chir.(Paris-France) Neurologie 1994 ; 17-076-D-10, 16p.
V. Heim P., Claussen M., Hoffmann B., and coll. Leukodystrophy Incidence in Germany. Am. J. Med. Genet 1997 ; 71:475-478.
VI. Bindu P.S., Mahadevan A., Taly A.B., and coll Peripheral Neuropathy in MetachromaLc Leucodystrophy. A Study of 40 Cases from South India J. Neurol. Neurosurg. Psychiatry 2005 ;76 :1698-1701.
VII. Tullu M.S., Muranjan M.N., Kondurkar P.P., Bharucha B.J. Krabbe Disease –Clinical Profil Indian Pediatr. 2000 ;37 :939-946.
VIII. Topcu M., Saatci I., Topcuoglu M.A., and coll. Megalencephaly and leukodystrophy with mil clinical course : a report on 12 new cases. Brain Dev. 1998 ;20 :142-153.
IX. [9]Traeger E.C., Rapin I. The Clinical Course of Canavan Disease Pediatr. Neurol. 1998 ;18 :207-212. [10] Parikh S, Bernard G, Leventer RJ, et al. A clinical approach to the diagnosis of paLents with leukodystrophies and geneLc leukoencephelopathies. Mol Genet Metab. 2015;114(4):501–515
X. [11] Mahmoud Reza Ashrafi, Man Amanat, Masoud Garshasbi, Reyhaneh Kameli, Yalda Nilipour, Morteza Heidari, Zahra Rezaei & Ali Reza Tavasoli . An update on clinical, pathological, diagnosLc, and therapeuLc perspecLves of childhood leukodystrophies. Expert Review of NeurotherapeuLc2020 janvier;20(1):65-84 . [12] Datar R, Prasad AN, Tay KY, et al. MagneLc resonance imaging in the diagnosis of white ma]er signal abnormaliLes. Neuroradiol J. 2018;31(4):362–371.
XI. Vanderver A, Prust M, TonduL D, et al. Case definiLon and classificaLon of leukodystrophies and leukoencephalopathies. Mol Genet Metab. 2015;114(4):494–500.
XII. DAVIE, C. A., BARKER, Gareth, TOFTS, P. S., et al. DetecLon of myelin breakdown products by proton magneLc resonance spectroscopy. The Lancet, 1993, vol. 341, no 8845, p. 630-631.
XIII. ABDELSALAM, Eman Muhammad, ASHAMALLAH, Germeen Albeir, LATEEF, Mahmoud Abdel, et al. Proton MR Spectroscopy in leukodystrophies. The EgypLan Journal of Radiology and Nuclear Medicine, 2015, vol. 46, no 4, p. 1091-1097.
XIV. Osterman B, La Piana R, Bernard G. Advances in the diagnosis of leukodystrophies. Future Neurol. 2012;7(5):595–612.
XV. Groeschel S, Kuhl JS, Bley AE, Kehrer C, Weschke B, Doring M, et al. Long-term outcome of allogeneic hematopoieLc stem cell transplantaLon in paLents with juvenile metachromaLc leukodystrophy compared with nontransplanted control paLents. JAMA Neurol. (2016) 73:1133–40.
doi: 10.1001/jamaneurol.2016.2067.
XVI. Stein A, Stroobants S, Gieselmann V, D’Hooge R, Matzner U. AnL-inflammatory therapy with simvastaLn improves neuroinflammaLon and CNS funcLon in a mouse model of metachromaLc leukodystrophy. Mol Ther. (2015) 23:1160–8.
XVII. FEDERICO, Antonio et DE VISSER, Marianne. New disease modifying therapies for two geneLc childhood-onset neurometabolic disorders (metachromaLc leucodystrophy and adrenoleucodystrophy). Neurological Sciences, 2021, vol. 42, p. 2603-2606.